Registration Dossier

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

In accordance with section 8.9.1 of Column 2 of Annex X of the REACH Regulation, a carcinogenicity study may be proposed if the substance has a widespread dispersive use or there is evidence of frequent long-term or human exposure and the substance is classified as a Category 2 germ cell mutagen.  As the substance does not have widerspread dispersive use, or frequent or long-term exposure, and since the substance bears no classification for genotoxicity, it is considered justified to omit the carcinogenicity study.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Link to relevant study records
Reference
Endpoint:
carcinogenicity
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
other:
Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Justification for classification or non-classification

In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No 1272/2008, the substance does not require classification with respect to carcinogenicity.